Bill Text - HB479 (2021)

(New Title) relative to pharmacist provider status, nicotine cessation therapy, and pharmacy benefit manager requirements.


Revision: July 8, 2021, 1:23 p.m.

July 6, 2021

2021-2057-EBA

04/08

 

Enrolled Bill Amendment to HB 479

 

The Committee on Enrolled Bills to which was referred HB 479

 

 

AN ACT relative to pharmacist provider status, nicotine cessation therapy, and pharmacy benefit manager requirements.

 

 

Having considered the same, report the same with the following amendment, and the recommendation that the bill as amended ought to pass.

 

FOR THE COMMITTEE

 

 

__________________________________

 

─────────────────────────────────────────────────────────────────

 

 

Explanation to Enrolled Bill Amendment to HB 479

 

This enrolled bill amendment renumbers a paragraph to avoid a conflict with current law as inserted by SB57 of the 2021 regular legislative session.

 

 

Enrolled Bill Amendment to HB 479

 

 

Amend the bill by replacing section 3 with the following:

 

3  New Paragraph; Pharmacists and Pharmacies; Definitions.  Amend RSA 318:1 by inserting after paragraph XXXV the following new paragraph:

XXXVI.  “Nicotine cessation therapy” means medications which the United States Food and Drug Administration (FDA) classifies as available by prescription or without a prescription for the purpose of nicotine cessation.